SE0400708D0 - New compounds and use thereof - Google Patents

New compounds and use thereof

Info

Publication number
SE0400708D0
SE0400708D0 SE0400708A SE0400708A SE0400708D0 SE 0400708 D0 SE0400708 D0 SE 0400708D0 SE 0400708 A SE0400708 A SE 0400708A SE 0400708 A SE0400708 A SE 0400708A SE 0400708 D0 SE0400708 D0 SE 0400708D0
Authority
SE
Sweden
Prior art keywords
new compounds
compounds
formula
cancer
preparing
Prior art date
Application number
SE0400708A
Other languages
English (en)
Swedish (sv)
Inventor
Jacob Westman
Klas Wiman
Galina Selivanova
Vladimir Bykov
Original Assignee
Aprea Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aprea Ab filed Critical Aprea Ab
Priority to SE0400708A priority Critical patent/SE0400708D0/xx
Publication of SE0400708D0 publication Critical patent/SE0400708D0/xx
Priority to PL05722253T priority patent/PL1727817T3/pl
Priority to US10/590,054 priority patent/US7759361B2/en
Priority to DK05722253.1T priority patent/DK1727817T3/da
Priority to DE602005023840T priority patent/DE602005023840D1/de
Priority to CA2552855A priority patent/CA2552855C/en
Priority to EP05722253A priority patent/EP1727817B1/de
Priority to PT05722253T priority patent/PT1727817E/pt
Priority to JP2007504913A priority patent/JP4904561B2/ja
Priority to PCT/SE2005/000412 priority patent/WO2005090341A1/en
Priority to AT05722253T priority patent/ATE482955T1/de
Priority to SI200531186T priority patent/SI1727817T1/sl
Priority to AU2005223728A priority patent/AU2005223728B2/en
Priority to ES05722253T priority patent/ES2349471T3/es
Priority to CY20101101187T priority patent/CY1111256T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE0400708A 2004-03-22 2004-03-22 New compounds and use thereof SE0400708D0 (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE0400708A SE0400708D0 (sv) 2004-03-22 2004-03-22 New compounds and use thereof
ES05722253T ES2349471T3 (es) 2004-03-22 2005-03-22 Derivados de azabiciclooctan-3-ona y su uso.
EP05722253A EP1727817B1 (de) 2004-03-22 2005-03-22 Azabicyclooctan-3-onderivate und deren verwendung
JP2007504913A JP4904561B2 (ja) 2004-03-22 2005-03-22 アザビシクロオクタン−３−オン誘導体及びその使用
DK05722253.1T DK1727817T3 (da) 2004-03-22 2005-03-22 Azabicyclooctan-3-onderivativer og anvendelse heraf
DE602005023840T DE602005023840D1 (de) 2004-03-22 2005-03-22 Azabicyclooctan-3-onderivate und deren verwendung
CA2552855A CA2552855C (en) 2004-03-22 2005-03-22 Azabicyclooctan-3-one derivatives and use thereof
PL05722253T PL1727817T3 (pl) 2004-03-22 2005-03-22 Pochodne azabicyklooktan-3-onu i ich zastosowanie
PT05722253T PT1727817E (pt) 2004-03-22 2005-03-22 Derivados de azabiciclooctan-3-ona e seu uso
US10/590,054 US7759361B2 (en) 2004-03-22 2005-03-22 Azabicyclooctan-3-one derivatives and use thereof
PCT/SE2005/000412 WO2005090341A1 (en) 2004-03-22 2005-03-22 Azabicyclooctan-3-one derivatives and use thereof
AT05722253T ATE482955T1 (de) 2004-03-22 2005-03-22 Azabicyclooctan-3-onderivate und deren verwendung
SI200531186T SI1727817T1 (sl) 2004-03-22 2005-03-22 Azabiciklooktan-3-onski derivati in njihova uporaba
AU2005223728A AU2005223728B2 (en) 2004-03-22 2005-03-22 Azabicyclooctan-3-one derivatives and use thereof
CY20101101187T CY1111256T1 (el) 2004-03-22 2010-12-23 Παραγωγα αζαδικυκλοοκταν-3-ονης και χρηση τους

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400708A SE0400708D0 (sv) 2004-03-22 2004-03-22 New compounds and use thereof

Publications (1)

Publication Number Publication Date
SE0400708D0 true SE0400708D0 (sv) 2004-03-22

Family

ID=32067464

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0400708A SE0400708D0 (sv) 2004-03-22 2004-03-22 New compounds and use thereof

Country Status (15)

Country Link
US (1) US7759361B2 (de)
EP (1) EP1727817B1 (de)
JP (1) JP4904561B2 (de)
AT (1) ATE482955T1 (de)
AU (1) AU2005223728B2 (de)
CA (1) CA2552855C (de)
CY (1) CY1111256T1 (de)
DE (1) DE602005023840D1 (de)
DK (1) DK1727817T3 (de)
ES (1) ES2349471T3 (de)
PL (1) PL1727817T3 (de)
PT (1) PT1727817E (de)
SE (1) SE0400708D0 (de)
SI (1) SI1727817T1 (de)
WO (1) WO2005090341A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007062030A2 (en) * 2005-11-21 2007-05-31 Ohio University Quinuclidinone derivatives as anticancer agents
IN2012DN05192A (de) * 2010-01-21 2015-10-23 Aprea Ab
CN104860994A (zh) * 2014-02-20 2015-08-26 中国药科大学 3-奎宁环酮类含磷化合物的制备及其医药用途
WO2017159877A1 (en) * 2016-03-18 2017-09-21 Eisai R&D Management Co., Ltd. Use of eribulin and 3-quinuclidinone derivatives in the treatment of cancer
CN109280054A (zh) * 2017-07-21 2019-01-29 上海时莱生物技术有限公司 氘代3-奎宁环酮类化合物、制备方法及用途
CN109280056A (zh) * 2017-07-21 2019-01-29 上海时莱生物技术有限公司 手性3-奎宁环酮类化合物、制备方法及用途
KR20210062044A (ko) * 2018-09-20 2021-05-28 아프레아 테라퓨틱스 에이비 퀴누클리딘-3-온 유도체와 암 치료에서 이의 용도
WO2021053155A1 (en) 2019-09-18 2021-03-25 Aprea Therapeutics Ab Combination treatment with a p53 reactivator and an inhibitor of an antiapoptotic bcl-2 family protein
WO2021170772A1 (en) 2020-02-26 2021-09-02 Aprea Therapeutics Ab Combination treatment with a p53 reactivator and an inhibitor of cd47 mediated signaling
WO2021180338A1 (en) 2020-03-09 2021-09-16 Aprea Therapeutics Ab Combination treatment with a p53 reactivator and an inhibitor of dna methyltransferase post stem cell transplant
WO2022175402A1 (en) 2021-02-18 2022-08-25 Aprea Therapeutics Ab Quinuclidine-3-one derivatives
WO2022204109A1 (en) * 2021-03-22 2022-09-29 Newave Pharmaceutical Inc. Quinuclidinone analogues as anticancer agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3384641A (en) * 1967-09-19 1968-05-21 Aldrich Chem Co Inc 2-methylene-3-quinuclidones
US3726877A (en) * 1970-10-28 1973-04-10 Univ Temple Amine substituted methylene quinuclidone anti-bacterial agents
US4599344A (en) * 1984-10-31 1986-07-08 Schering A.G. Quinuclidines and quinuclidinium salts as antiarrhythmic agents
DE69105131T2 (de) * 1990-06-01 1995-03-23 Pfizer 3-amino-2-arylchinuclidine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
US6953855B2 (en) * 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US6432975B1 (en) * 1998-12-11 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
WO2002017358A2 (en) * 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
WO2002024692A1 (en) 2000-09-20 2002-03-28 Karolinska Innovations Ab 1-azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
US7659278B2 (en) 2002-02-21 2010-02-09 Aprea Ab Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases
NZ542212A (en) * 2003-03-24 2008-04-30 Aprea Ab Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive WT P53
SE0300812D0 (sv) 2003-03-24 2003-03-24 Karolinska Innovations Ab Use of chemical compounds for preparing pharmaceutical compositions, and method of testing substances for medical effect

Also Published As

Publication number Publication date
ATE482955T1 (de) 2010-10-15
JP4904561B2 (ja) 2012-03-28
CA2552855C (en) 2012-08-14
DK1727817T3 (da) 2011-01-10
US20070142370A1 (en) 2007-06-21
ES2349471T3 (es) 2011-01-03
AU2005223728B2 (en) 2011-02-10
SI1727817T1 (sl) 2011-01-31
PT1727817E (pt) 2010-10-26
PL1727817T3 (pl) 2011-03-31
JP2007530534A (ja) 2007-11-01
WO2005090341A1 (en) 2005-09-29
US7759361B2 (en) 2010-07-20
EP1727817B1 (de) 2010-09-29
CA2552855A1 (en) 2005-09-29
CY1111256T1 (el) 2015-08-05
AU2005223728A1 (en) 2005-09-29
EP1727817A1 (de) 2006-12-06
DE602005023840D1 (de) 2010-11-11

Similar Documents

Publication Publication Date Title
CY1111256T1 (el) Παραγωγα αζαδικυκλοοκταν-3-ονης και χρηση τους
SE0200920D0 (sv) Novel compounds
SE0202539D0 (sv) Compounds
SE0102299D0 (sv) Compounds
SE0102300D0 (sv) Compounds
EA200700225A1 (ru) Аналоги тетрапептида
ATE433447T1 (de) Pyrimiidinverbindungen
SE0301700D0 (sv) Novel compounds
SE0300480D0 (sv) Novel compounds
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
IS7965A (is) Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi
SE0401762D0 (sv) Novel compounds
SE0302811D0 (sv) Novel compounds
SE0104140D0 (sv) Novel Compounds
TW200613243A (en) Novel compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
UA83691C2 (ru) Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона
UA85559C2 (en) Aminobenzophenone compounds
GB0112348D0 (en) Compounds
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
SE0302139D0 (sv) Novel compounds
CR9182A (es) Derivado de quinolina, su uso, preparacion y medicamento que lo contiene
EA200701930A1 (ru) Производные пиримидина для лечения гиперпролиферативных нарушений
SE0402925D0 (sv) Novel Compounds
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen